{
    "clinical_study": {
        "@rank": "151387", 
        "acronym": "NIMRAD", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo given in parallel with radiotherapy for 6 weeks."
            }, 
            {
                "arm_group_label": "Nimorazole", 
                "arm_group_type": "Experimental", 
                "description": "Nimorazole given in parallel with radiotherapy for 6 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to see whether adding Nimorazole to standard radiotherapy\n      benefits patients with locally advanced head and neck squamous cell carcinoma."
        }, 
        "brief_title": "NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)", 
        "completion_date": {
            "#text": "June 2020", 
            "@type": "Anticipated"
        }, 
        "condition": "Head and Neck Squamous Cell Carcinoma", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Squamous Cell", 
                "Head and Neck Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically confirmed head and neck squamous cell carcinoma; all primary subsites\n             EXCEPT nasal cavity, oral cavity, nasopharynx and paranasal sinus (i.e. oropharynx,\n             hypopharynx, larynx are allowed)\n\n          -  Stage T3/T4 N0; any node +ve case including T1 node +ve; T2N0 base of\n             tongue/hypopharnx\n\n          -  Pateints suitable for definitive radiotherapy.  Block dissections may be performed\n             pre-RT for N2/N3 disease\n\n          -  WHO status 0-2\n\n          -  Patient fit and able to undergo RT with nimorazole and be expected to complete\n             treatment\n\n          -  Absence of another disease or previous malignancy which is likely to interfere with\n             the treatment or assessment of response\n\n          -  No evidence of distant metasteses (M0)\n\n          -  Unable to tolerate/unlikely to benefit from platinum chemotherapy or monoclonal\n             antibody therapy\n\n          -  Women must be postmenopausal (no menstrual period for a minimum of 1 year) or have a\n             negative serum pregnancy test on entry in the study (even if surgically sterilised)\n\n          -  Greater than 18 years of age; no upper age limit\n\n          -  written informed consent\n\n          -  available for follow up within the United Kingdom\n\n          -  Adequate renal and liver function - absolute neurophil count >=1.5 x 109/L,\n             creatinine <=2x ULN, platelets > 100x109/L, bilirubin <=2 x ULN, AST <3 x ULN\n\n          -  The capacity to understand the patient information sheet and the ability to provide\n             written informed consent.\n\n          -  Willingness and ability to comply with scheduled visits, treatment plans, laboratory\n             tests and other study procedures.\n\n        Exclusion Criteria:\n\n          -  Patients with T1N0 tumours or those within the nasopharynx, nasal cavity or sinus,\n             oral cavity; T2No larynx and tonsil; unknown primary cancer.\n\n          -  Any prior chemotherapy in the last 6 months or RT within the planned radiation field\n\n          -  Presence of any life threatening illness such as unstable angina or severe chronic\n             obstructive pulmonary disease\n\n          -  Mental disability or patient otherwise unable to give informed consent and/or\n             complete patient questionnaires\n\n          -  Hb <100 g/l (patients with anaemia may be transfused to bring Hb levels to >100 g/l\n             within 1 week of treatment start)\n\n          -  Peripheral neurophathy as assessed clinically (CTCAE >=2)\n\n          -  Use of any investigational drug within 30 days prior to screening\n\n          -  Severe and/or uncontrolled medical disease\n\n          -  Any malabsorption syndrome (i.e. partial gastrectomy, small bowel resection, Crohn's\n             disease or ulcerative colitis)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "470", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01950689", 
            "org_study_id": "CFTSp032, 11_DOG08_53"
        }, 
        "intervention": [
            {
                "arm_group_label": "Nimorazole", 
                "intervention_name": "Nimorazole", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Placebo", 
                    "Nimorazole"
                ], 
                "intervention_name": "Radiotherapy", 
                "intervention_type": "Radiation"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Nimorazole", 
                "Cetuximab"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 23, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Cheltenham", 
                        "country": "United Kingdom", 
                        "state": "Gloucestershire", 
                        "zip": "GL53 7AN"
                    }, 
                    "name": "Cheltenham general hospital"
                }, 
                "investigator": {
                    "last_name": "Stephen Shepherd", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bebington", 
                        "country": "United Kingdom", 
                        "state": "Merseyside", 
                        "zip": "CH63 4JY"
                    }, 
                    "name": "Clatterbridge centre for oncology"
                }, 
                "investigator": {
                    "last_name": "David Husband", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leeds", 
                        "country": "United Kingdom", 
                        "state": "West Yorkshire", 
                        "zip": "LS9 7TF"
                    }, 
                    "name": "St James' Hospital"
                }, 
                "investigator": {
                    "last_name": "Mehmet Sen", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Belfast", 
                        "country": "United Kingdom", 
                        "zip": "BT9 7AB"
                    }, 
                    "name": "Belfast City Hospital"
                }, 
                "investigator": {
                    "last_name": "Russell Houston", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United Kingdom", 
                        "zip": "B15 2TH"
                    }, 
                    "name": "Queen Elizabeth hospital"
                }, 
                "investigator": {
                    "last_name": "Andrew Hartley", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bristol", 
                        "country": "United Kingdom", 
                        "zip": "BS2 8ED"
                    }, 
                    "name": "Bristol Haematology and Oncology centre"
                }, 
                "investigator": {
                    "last_name": "Hoda Booz", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cambridge", 
                        "country": "United Kingdom", 
                        "zip": "CB2 0QQ"
                    }, 
                    "name": "Addenbrookes Hospital"
                }, 
                "investigator": {
                    "last_name": "Richard Benson", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cardiff", 
                        "country": "United Kingdom", 
                        "zip": "CF14 2TL"
                    }, 
                    "name": "Velindre Cancer Centre"
                }, 
                "investigator": {
                    "last_name": "Mererid Evans", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom", 
                        "zip": "G12 0YN"
                    }, 
                    "name": "The Beatson west of scotland cancer centre"
                }, 
                "investigator": {
                    "last_name": "Mohammed Rizwanullah", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guildford", 
                        "country": "United Kingdom", 
                        "zip": "GU2 7XX"
                    }, 
                    "name": "The Royal Surrey County Hospital"
                }, 
                "investigator": {
                    "last_name": "Stephen Whitaker", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "SW3 6JJ"
                    }, 
                    "name": "The Royal Marsden"
                }, 
                "investigator": {
                    "last_name": "Chris Nutting", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Manchester", 
                        "country": "United Kingdom", 
                        "zip": "M20 4BX"
                    }, 
                    "name": "The Christie NHS Foundation Trust"
                }, 
                "investigator": {
                    "last_name": "Nick Slevin", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Middlesex", 
                        "country": "United Kingdom", 
                        "zip": "HA6 2RN"
                    }, 
                    "name": "Mount Vernon"
                }, 
                "investigator": {
                    "last_name": "Kate Goodchild", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newcastle", 
                        "country": "United Kingdom", 
                        "zip": "NE7 7DN"
                    }, 
                    "name": "Freeman hospital"
                }, 
                "investigator": {
                    "last_name": "Charles Kelly", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nottingham", 
                        "country": "United Kingdom", 
                        "zip": "NG5 1PB"
                    }, 
                    "name": "Nottingham University hospitals"
                }, 
                "investigator": {
                    "last_name": "Judith Christian", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Preston", 
                        "country": "United Kingdom", 
                        "zip": "PR2 9HT"
                    }, 
                    "name": "Royal Preston hospital"
                }, 
                "investigator": {
                    "last_name": "Muthiah Sivaranalingam", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sheffield", 
                        "country": "United Kingdom", 
                        "zip": "S10 2SJ"
                    }, 
                    "name": "Weston Park Hospital"
                }, 
                "investigator": {
                    "last_name": "Bernadette Foran", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Swansea", 
                        "country": "United Kingdom", 
                        "zip": "SA2 8QA"
                    }, 
                    "name": "Singleton Hospital"
                }, 
                "investigator": {
                    "last_name": "Martin Rolles", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)", 
        "overall_contact": {
            "email": "suzanne.rowland@christie.nhs.uk", 
            "last_name": "Suzanne Rowland"
        }, 
        "overall_official": {
            "affiliation": "The Christie NHS Foundation Trust", 
            "last_name": "Nick Slevin", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To examine whether patients with locally advanced head and neck squamous cell carcinoma unsuitable for either cisplatin chemotherapy or monoclonal antibody therapy benefit from the addition of nimorazole to standard definitive radiotherapy in terms of increased locoregional control without additional serious toxicity.", 
            "measure": "Locoregional Control", 
            "safety_issue": "No", 
            "time_frame": "12 weeks post treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01950689"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Christie Hospital NHS Foundation Trust", 
            "investigator_full_name": "Suzanne Rowland", 
            "investigator_title": "Clinical Trials Project Manager", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Overall survival", 
                "safety_issue": "No", 
                "time_frame": "Date of death for patient, month 60."
            }, 
            {
                "measure": "Cancer-specific survival", 
                "safety_issue": "No", 
                "time_frame": "follow up month 60"
            }, 
            {
                "measure": "Disease-free survival", 
                "safety_issue": "No", 
                "time_frame": "follow up month 60"
            }, 
            {
                "measure": "Cumulative incidence of loco-regional failure", 
                "safety_issue": "No", 
                "time_frame": "follow up month 60"
            }, 
            {
                "measure": "Acute toxicity", 
                "safety_issue": "Yes", 
                "time_frame": "baseline, week 1, 2, 3, 4, 5, 6, follow up month 1.5 and 3"
            }, 
            {
                "measure": "Hypoxia signature prediction of nimorazole benefit", 
                "safety_issue": "No", 
                "time_frame": "screening"
            }, 
            {
                "measure": "quality of life", 
                "safety_issue": "No", 
                "time_frame": "baseline, week 6, month 6, 12, 18, 24, 36 of follow up"
            }, 
            {
                "measure": "Late toxicity", 
                "safety_issue": "Yes", 
                "time_frame": "baseline, follow up month 6, 12, 18, 24, 36"
            }
        ], 
        "source": "Christie Hospital NHS Foundation Trust", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Christie Hospital NHS Foundation Trust", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}